LT3705B - Transdermal therapeutical system and process for the production thereof - Google Patents

Transdermal therapeutical system and process for the production thereof Download PDF

Info

Publication number
LT3705B
LT3705B LTIP1589A LTIP1589A LT3705B LT 3705 B LT3705 B LT 3705B LT IP1589 A LTIP1589 A LT IP1589A LT IP1589 A LTIP1589 A LT IP1589A LT 3705 B LT3705 B LT 3705B
Authority
LT
Lithuania
Prior art keywords
therapeutic system
transdermal therapeutic
matrix
transdermal
physostigmine
Prior art date
Application number
LTIP1589A
Other languages
English (en)
Lithuanian (lt)
Inventor
Thomas Hille
H-Rainer Hoffmann
Hans-Joachim Huber
Axel Knoch
Gerhard Schneider
Fritz Stanislaus
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of LTIP1589A publication Critical patent/LTIP1589A/xx
Publication of LT3705B publication Critical patent/LT3705B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
LTIP1589A 1988-12-22 1993-12-14 Transdermal therapeutical system and process for the production thereof LT3705B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843238A DE3843238C1 (nl) 1988-12-22 1988-12-22

Publications (2)

Publication Number Publication Date
LTIP1589A LTIP1589A (en) 1995-06-26
LT3705B true LT3705B (en) 1996-02-26

Family

ID=6369854

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1589A LT3705B (en) 1988-12-22 1993-12-14 Transdermal therapeutical system and process for the production thereof

Country Status (29)

Country Link
US (1) US5391375A (nl)
EP (1) EP0377147B1 (nl)
JP (1) JPH0784380B2 (nl)
KR (1) KR950015057B1 (nl)
CN (1) CN1044226A (nl)
AT (1) ATE105489T1 (nl)
AU (1) AU613814B2 (nl)
CA (1) CA2006398C (nl)
CS (1) CS277067B6 (nl)
DD (1) DD290582A5 (nl)
DE (2) DE3843238C1 (nl)
DK (1) DK651189A (nl)
ES (1) ES2057080T3 (nl)
FI (1) FI95774C (nl)
GE (1) GEP19980993B (nl)
HU (1) HU206041B (nl)
IE (1) IE64834B1 (nl)
IL (1) IL92679A0 (nl)
LT (1) LT3705B (nl)
LV (1) LV10383B (nl)
MY (1) MY105073A (nl)
NO (1) NO180107C (nl)
NZ (1) NZ231908A (nl)
PH (1) PH25852A (nl)
PL (1) PL160971B1 (nl)
PT (1) PT92651B (nl)
RU (1) RU2052997C1 (nl)
YU (1) YU47076B (nl)
ZA (1) ZA899882B (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843239C1 (nl) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
EP0607453B1 (en) * 1992-07-13 2002-05-08 Seiko Epson Corporation Surface illumination device and liquid crystal display
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE4429791C2 (de) * 1994-08-23 1997-04-24 Lohmann Therapie Syst Lts Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
ES2323940T3 (es) * 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
CA2517929A1 (en) * 2003-03-06 2004-09-16 Accera Inc. Novel-chemical entities and methods for their use in treatment of metabolic disorders
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
EP1915144A4 (en) * 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
EP2500017B1 (en) 2006-04-03 2017-09-06 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
PT2650380E (pt) 2007-07-31 2016-01-14 Accera Inc Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida
CA2729622C (en) * 2008-07-03 2017-07-25 Accera, Inc. Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
US8105809B2 (en) * 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
ITPI20090066A1 (it) * 2009-05-26 2010-11-27 Consiglio Nazionale Ricerche Metodo per produrre un dispositivo applicabile a tessuti biologici, in particolare un patch per trattare tessuti danneggiati, e dispositivo ottenuto con tale metodo
DE102009056745A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
US8828181B2 (en) 2010-04-30 2014-09-09 E I Du Pont De Nemours And Company Temperature switchable adhesives comprising a crystallizable oil
US8409703B2 (en) 2010-07-23 2013-04-02 E I Du Pont De Nemours And Company Temperature switchable adhesive assemblies with temperature non-switchable tack
DE102019201431A1 (de) 2019-02-05 2020-08-06 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit Feststoffreservoir
DE102019201430A1 (de) 2019-02-05 2020-08-06 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit Transportmedium
AU2020306028A1 (en) * 2019-06-28 2022-02-03 Passport Technologies, Inc. Transdermal drug delivery patch, drug delivery system and drug delivery method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US921363A (en) 1908-07-09 1909-05-11 William L Chrysler Pitman connection.
DE3606892A1 (de) 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
JPS5620514A (en) * 1979-07-27 1981-02-26 Nitto Electric Ind Co Ltd Plaster for remedy of skin disease
JPS596285B2 (ja) * 1980-09-22 1984-02-10 日東電工株式会社 外用部材
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS58148815A (ja) * 1982-02-26 1983-09-05 Nitto Electric Ind Co Ltd 複合医薬製剤の製法
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
DE3843239C1 (nl) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US921363A (en) 1908-07-09 1909-05-11 William L Chrysler Pitman connection.
DE3606892A1 (de) 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
ES2057080T3 (es) 1994-10-16
DE3843238C1 (nl) 1990-02-22
LTIP1589A (en) 1995-06-26
NO895172D0 (no) 1989-12-21
CN1044226A (zh) 1990-08-01
EP0377147A2 (de) 1990-07-11
HU896714D0 (en) 1990-02-28
CA2006398A1 (en) 1990-06-22
HUT54043A (en) 1991-01-28
DD290582A5 (de) 1991-06-06
NZ231908A (en) 1991-10-25
AU613814B2 (en) 1991-08-08
KR950015057B1 (ko) 1995-12-21
LV10383A (lv) 1995-02-20
US5391375A (en) 1995-02-21
IE64834B1 (en) 1995-09-06
RU2052997C1 (ru) 1996-01-27
PT92651A (pt) 1990-06-29
NO895172L (no) 1990-06-25
FI95774C (fi) 1996-03-25
CA2006398C (en) 1997-04-15
AU4684489A (en) 1990-06-28
ATE105489T1 (de) 1994-05-15
DE58907649D1 (de) 1994-06-16
HU206041B (en) 1992-08-28
EP0377147A3 (en) 1990-12-27
NO180107C (no) 1997-02-26
JPH0784380B2 (ja) 1995-09-13
MY105073A (en) 1994-07-30
DK651189A (da) 1990-06-23
LV10383B (en) 1995-10-20
JPH0315476A (ja) 1991-01-23
NO180107B (no) 1996-11-11
DK651189D0 (da) 1989-12-20
FI95774B (fi) 1995-12-15
YU240689A (en) 1991-04-30
GEP19980993B (en) 1998-03-26
FI896098A0 (fi) 1989-12-19
CS719289A3 (en) 1992-06-17
YU47076B (sh) 1994-12-28
KR900009064A (ko) 1990-07-02
IL92679A0 (en) 1990-09-17
PT92651B (pt) 1995-09-12
PH25852A (en) 1991-12-02
IE894078L (en) 1990-06-22
PL160971B1 (en) 1993-05-31
CS277067B6 (en) 1992-11-18
EP0377147B1 (de) 1994-05-11
ZA899882B (en) 1990-09-26

Similar Documents

Publication Publication Date Title
LT3705B (en) Transdermal therapeutical system and process for the production thereof
KR950015058B1 (ko) 활성 성분으로 피소스티그민을 함유하는 경피 치료 시스템 및 그 제조방법
RU2400216C2 (ru) Система трансдермальной доставки никотина
BRPI0621655A2 (pt) preparação para a absorção percutánea de uma droga antidemência básica
CN107468673A (zh) 透皮施用美金刚
DK175774B1 (da) Farmaceutisk præparat til transdermal systemisk administration af et farmakologisk aktivt middel, fremgangsmåde til fremstilling deraf samt anvendelse af ketotifen til fremstilling af et lægemiddel
JPH06500126A (ja) エルゴリン誘導体を含有する経皮適用薬
JP2003511408A (ja) アセチルサリチル酸および／またはサリチル酸投与用の経皮治療システム
AU725245B2 (en) Extensible transdermal therapeutic system
KR102127531B1 (ko) 부착 제제
JPH09509154A (ja) 活性物質モルフィン−６−グルクロニドを含む全身的経皮投与用医薬組成物
RU2108812C1 (ru) Трансдермальная терапевтическая система и способ ее получения
Ali et al. Preparation and evaluation of domperidone transdermal patches
DK175236B1 (da) Farmaceutisk præparat
HRP930588A2 (en) Therapeutic transdermal system having physostigmine as an active ingredient, and process for its development
SI8912407A (sl) Postopek za izdelavo transdermalnega terapevtskega sistema z fizostigminom kot dejavno sestavino
MXPA99007363A (en) Extendible transdermal therapeutic system

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20001214